Holen Sie sich die Stockscreener-App
1.9122
0.79%
0.0222
Schlusskurs vom Vortag:
$1.89
Offen:
$1.96
24-Stunden-Volumen:
8,273
Relative Volume:
0.01
Marktkapitalisierung:
$1.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-5.02M
KGV:
-0.2252
EPS:
-8.4895
Netto-Cashflow:
$-3.96M
1W Leistung:
-16.81%
1M Leistung:
-9.29%
6M Leistung:
-63.71%
1J Leistung:
-83.86%
1-Tages-Spanne:
$1.8701
$1.96
1-Wochen-Bereich:
$1.86
$2.27
52-Wochen-Spanne:
$1.7968
$17.95
Prf Technologies Ltd Stock (PRFX) Company Profile
Compare PRFX vs TAK, ZTS, TEVA, HLN, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRFX
Prf Technologies Ltd
|
1.8701 | 1.60M | 0 | -5.02M | -3.96M | -8.4895 |
TAK
Takeda Pharmaceutical Co Adr
|
16.63 | 52.51B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
113.10 | 48.01B | 9.47B | 2.67B | 2.28B | 6.0218 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.66 | 40.70B | 17.52B | 1.58B | 1.06B | 1.3428 |
HLN
Haleon Plc Adr
|
9.2902 | 41.69B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
575.15 | 24.21B | 3.18B | 1.33B | 1.04B | 27.90 |
Prf Technologies Ltd Aktie (PRFX) Neueste Nachrichten
EXCLUSIVE: PRF Technologies Advances Drop-Less Drug For Cataract Surgery Pain - Yahoo Finance
FDA clears PRF Technologies’ IND for cataract surgery treatment - Investing.com UK
FDA clears PRF Technologies’ IND for cataract surgery treatment By Investing.com - Investing.com South Africa
PRFX Receives FDA Clearance for OcuRing-K Clinical Trials - GuruFocus
PRF Technologies Wins FDA IND Clearance for OcuRing-K Phase II Cataract Trial - TipRanks
FDA clears PRF Technologies (PRFX) IND for OcuRing-K Phase II eye trial - Stock Titan
PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial - The Manila Times
PRF Technologies Ltd. Announces FDA Clearance Of IND Application For OcuRing-K Phase II Clinical Trial - marketscreener.com
PRF Technologies Ltd. Ordinary Shares (PRFX) posts far wider Q1 2024 loss than analyst estimates, sending its shares down 2.18% today.Customer Loyalty - Cổng thông tin điện tử tỉnh Tây Ninh
PRFX (PRF Technologies Ltd. Ordinary Shares) reports far wider Q1 2024 loss than estimates, shares dip modestly today.Hot Momentum Watchlist - Cổng thông tin điện tử tỉnh Tây Ninh
Ellen S Baron Net Worth (2026) - GuruFocus
Sigal Aviel Net Worth (2026) - GuruFocus
Ehud Geller Net Worth (2026) - GuruFocus
Eyal Broder Net Worth (2026) - GuruFocus
Efraim Cohen Arazi Net Worth (2026) - GuruFocus
Asaf Shavit Net Worth (2026) - GuruFocus
PRF Technologies (PRFX) Stock: Valuation Perspective (-2.18%) 2026-04-15Expert Breakout Alerts - UBND thành phố Hải Phòng
What's Going On With Pharma Company PRF Technologies On Tuesday? - Sahm
Morning Market Movers: ADVB, SKYQ, FCUV, KPRX See Big Swings - RTTNews
12 Health Care Stocks Moving In Monday's After-Market SessionAditxt (NASDAQ:ADTX), Advanced Biomed (NA - Benzinga
12 Health Care Stocks Moving In Monday's Intraday SessionABVC BioPharma (NASDAQ:ABVC), Aditxt (NASDAQ - Benzinga
PRF Technologies Sees Strategic Growth with DeepSolar Expansion - StocksToTrade
PRF Technologies Expands Global Solar Reach: Strategic Partnership with Blade Ranger - timothysykes.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
$PRF Technologies (PRFX.US)$ 🫡 out .91 - Moomoo
Is PRF Technologies (PRFX) Stock Breaking Resistance | Price at $2.63, Up 25.24%Crowd Sentiment Stocks - Newser
PRFX PE Ratio & Valuation, Is PRFX Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
PRFX SEC FilingsPRF Technologies Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
PRFX Should I Buy - Intellectia AI
PRF Technologies Posts 2025 Results as LayerBio and DeepSolar Deals Drive Dual-Platform Pivot - The Globe and Mail
PRF Technologies reports 2025 results, advances drug delivery platform By Investing.com - Investing.com Australia
PRF Technologies reports 2025 results, advances drug delivery platform - Investing.com
[6-K] PRF Technologies Ltd. Current Report (Foreign Issuer) | PRFX SEC FilingForm 6-K - Stock Titan
PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across ... - Bluefield Daily Telegraph
PRF Technologies Provides Year-End 2025 Business Update - GlobeNewswire
PRF Technologies (NASDAQ: PRFX) 20-F details going concern risk and cash needs - Stock Titan
PRF Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
PRF Technologies Ltd. Auditor Raises 'Going Concern' Doubt - marketscreener.com
CONNECTICUT LIGHT & POWER CO 2.09% PRF USD100 SER'F' To Go Ex-Dividend On April 10th, 2026 With 0.5225 USD Dividend Per Share - Moomoo
PRF Technologies (PRFX) COO lists vested and future option rights - Stock Titan
Director at PRF Technologies (PRFX) discloses stock option holdings - Stock Titan
PRF Technologies (PRFX) interim CEO lists stock option holdings - Stock Titan
PRF Technologies (PRFX) exec chair discloses vested stock option positions - stocktitan.net
PRF Technologies (PRFX) CFO discloses existing stock option grants - Stock Titan
Director Augustine Lawlor details option holdings in PRF Technologies (PRFX) - Stock Titan
PRF Technologies (PRFX) director holds 3,000 employee stock options - stocktitan.net
PRF Technologies Ltd. and Blade Ranger Ltd. Enter Commercial Collaboration Agreement - marketscreener.com
PRFX Teams Up with Blade Ranger to Boost Solar Platform Expansio - GuruFocus
PRF Technologies Taps Blade Ranger to Drive Utility-Scale DeepSolar Deals - TipRanks
Prf Technologies Ltd. announces commercial collaboration agreement with Blade Ranger to accelerate large-scale Deepsolar commercial engagements - marketscreener.com
Finanzdaten der Prf Technologies Ltd-Aktie (PRFX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):